<DOC>
	<DOCNO>NCT00364442</DOCNO>
	<brief_summary>A new formulation Fluticasone propionate/Salmeterol compare low dose fluticasone propionate salmeterol compare concurrent administration fluticasone propionate salmeterol . Administration occur 14 day tolerability , PK ( pharmacokinetic ) PD ( pharmacodynamic ) measurement perform .</brief_summary>
	<brief_title>Repeat Dose Study Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : Documented history mild intermittent asthma Have PEF FEV1 &gt; 80 % predict Not smoker BMI 19 29 Exclusion criterion : Have life threaten episode asthma Have respiratory tract infection last four week Have respiratory disease Have take certain medication within restricted time period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>asthma</keyword>
</DOC>